The initial process R&D phase of a drug candidate begins with screening. Screening can involve the investigation of solvent effects, reagent effects, etc. on a candidate’s activity level. The increased demand for more compounds released in a shorter period of time has resulted in a dramatic rise in the number of candidates that are screened per released drug. The level of screening candidates has now reached 10,000+ for every drug released to market.